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Background: Ureteroceles are a rare condition in dogs in which conventional treatments can
result in substantial morbidity. Cystoscopic and fluoroscopic-guided laser ablation (CLA) of ure-
teroceles can successfully relieve obstruction.
Objectives: To describe the technique and outcomes of attempting CLA for treatment of ureter-
oceles in dogs.
Animals: Thirteen client-owned dogs that underwent CLA for treatment of ureteroceles.
Methods: Retrospective multicentered study. Medical records were reviewed in all dogs that
underwent CLA for ureterocele(s). A laser was used to extend the opening of the ureteral orifice
(UO) unless surgical conversion was necessary. Data collected included signalment, clinicopatho-
logic data, imaging, procedural findings, complications, and short- and long-term outcome.
Results: Thirteen dogs with 13 ureteroceles associated with 14 UOs resulting in ureteral
obstruction were included. One ureterocele extended bilaterally. Treatment was initiated via
retrograde cystoscopy (7 females), percutaneous perineal urethrocystoscopy (4 males), or percu-
taneous antegrade cystoscopy (2 males). Surgical conversion was necessary in 2 males. Ten of
14 (71%) UOs associated with the ureteroceles were ectopic. Thirteen of 14 had stenotic or
imperforate UOs. No postoperative complications were noted. Preoperative incontinence or
pollakiuria was present in 9 of 13 and 3 of 13 dogs and resolved in 8 of 9 and 3 of 3 dogs,
respectively. Follow-up imaging showed resolution of all ureteroceles and improved ureteral/
renal pelvic dilatation. Median follow-up time was 27 months (range, 3-96 months).
Conclusions and Clinical Importance: Cystoscopic-guided laser ablation was effective for the
treatment of ureteroceles(s) in 11 of 13 dogs.
KEYWORDS
canine, interventional endoscopy, interventional radiology
1 | INTRODUCTION
A ureterocele is a cystic dilatation of the terminal ureter and is a rare
condition in dogs.1,2 Ureteroceles are classified as orthotopic if the
associated ureteral orifice (UO) is in a normal position or ectopic if
the UO is distal to the normal position in the trigone.3 Ureteroceles
can be clinically silent or clinical signs can develop secondary to chronic
ureterovesicular junction (UVJ) obstruction, urinary tract infections
(UTIs), urethral or trigonal outflow tract obstructions, or from altered
urine flow dynamics.2 Ureterovesicular junction obstruction or UTIs
accompanying ureteroceles can result in secondary changes including
hydroureter, hydronephrosis, and progressive renal dysfunction.2
Goals for management include prevention of renal damage associ-
ated with UVJ obstruction, vesicoureteral reflux, and UTIs, as well as pro-
motion of urinary continence and minimization of morbidity.2 In human
Abbreviations: APC, antegrade percutaneous cystourethroscopy; CLA, cysto-
scopic-guided ureteral ablation; CT, computed tomography; Hol:YAG, holmium,
yttrium, aluminum, and garnet laser; PPAC, percutaneous perineal access
cystourethroscopy; UO, ureteral orifice; UTI, urinary tract infection; UVJ, ure-
terovesicular junction.
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medicine, treatment options include endoscopic ureterocele decompres-
sion via incision, puncture, or balloon dilatation;4–6 laparoscopic or
robotic reimplantation;7–10 or various surgical techniques.2,5,11 Endo-
scopic decompression for single-system ureteroceles is considered to be
standard of care for initial intervention in human medicine.2,3,12,13
In veterinary medicine, a small number of published reports exist of
ureteroceles in dogs.14–30 Renal-sparing interventions were performed in
only 15 of 21 cases.14,15,17,20,22–25,27,29,30 Historically, surgical manage-
ment of ureteroceles in dogs has been the mainstay of treatment.14,17
Techniques include ureteronephrectomy, neoureterocystostomy, ureter-
ocelectomy, and intravesicular incision via electrocautery or a scalpel
blade.23 Complications include ureteral dehiscence, cystic dehiscence,
ureteral stricture, uroabdomen, and incisional infections.2,13–27,31 Because
of procedural morbidity associated with surgical techniques, additional
investigation into novel techniques is warranted.14–28
Cystoscopic and fluoroscopic-guided laser ablation (CLA) is reported
as a therapeutic modality for ureteroceles in dogs.3,15,29,30 However, to
date, a single case report exists describing the use of CLA for treatment
of unilateral orthotopic ureterocele in a female dog with follow-up.29
This case report documented resolution of pollakiuria and ultrasono-
graphic resolution of hydroureter with persistent mild pyelectasia; how-
ever, only 6 weeks of follow-up was available.29 An additional case
series describes CLA for the treatment of congenital distal UO stenosis
in 16 dogs that included 4 dogs with ureteroceles.30 However, out-
comes for dogs with ureteroceles were not separated from those lacking
ureteroceles.30
To the authors' knowledge, no published series exist evaluating
long-term outcomes for dogs specifically with ureteroceles treated
with any therapeutic modality. Thorough descriptions are lacking of
CLA for male dogs with ureteroceles and for female dogs with ectopic
ureteroceles. Standardized long-term outcomes like continence scores,
assessment of renal function, and imaging are also lacking.3,14–27,29,30 In
this study, we describe the technique and clinical outcome of attempted
CLA for the treatment of ureteroceles in dogs. The hypothesis is that
CLA for the treatment of ureteroceles in dogs is safe, effective, and
associated with minimal morbidity.
2 | MATERIALS AND METHODS
2.1 | Case selection
A retrospective review of medical records from the Animal Medical
Center of New York City and the Small Animal Hospital of Purdue Uni-
versity was performed for all dogs diagnosed with a ureterocele and
with CLA attempted from March 2008 to April 2017. Each ureterocele
was identified preoperatively via ultrasound, computed tomography
(CT), or both modalities, and definitively diagnosed cystoscopically,
fluoroscopically, or via laparotomy for inclusion in the study.
2.2 | Medical records review
Data collected included signalment, clinical signs, physical examination
findings, continence scores, diagnostic imaging findings, laboratory bio-
chemical, hematologic, and microbiologic findings, procedural report,
length of the procedure, and complications. Preoperative, intraopera-
tive, and postoperative (short-term [<30 days], long-term [>30 days])
were recorded. Incontinence was defined as any persistent or intermit-
tent involuntary leakage of urine. Continence was graded on a scale of
1 through 10,32 where 1 was minimally continent (leaking all the time),
5 was moderately continent (leaking when lying down or when the
bladder is full but able to hold urine between urinations and to produce
a normal stream and volume of urine), and 10 was perfectly continent
(no leakage at all). If omitted from the record, continence scores were
assigned retrospectively. Follow-up information was obtained via medi-
cal record or telephone interview with the owner of each dog or pri-
mary veterinarian. Ultrasound reports were generated by radiologists,
internists, and general practitioners. Computed tomography reports
were generated by radiologists. Images were not retrospectively reviewed.
Information regarding presence of a ureterocele, renal architecture, renal
pelvic diameter, ureteral diameter, and ureteral ectopia was recorded.
2.3 | Procedures
Cystoscopic laser procedures were performed by the authors A. C.
Berent or L. G. Adams. Female dogs had retrograde cystourethroscopy
with a rigid cystoscope (2.7 or 4 mm) (rigid endoscope, 2.7 mm 30
lens with 14 fr integrated sheath, Richard Wolf, Vernon Hills, Illinois;
rigid endoscope, 2.7 mm 30 lens, Karl Storz Endoscopy-America,
Culver City, California; Cystoscope-urethroscope sheath, 14.5 fr, Karl
Storz Endoscopy-America; rigid endoscope, 4.0 mm 30 lens, Karl
Storz Endoscopy-America; cystoscope-urethroscope sheath, 19 fr,
Karl Storz Endoscopy-America) with a 30 angle performed to evalu-
ate the vestibule, vagina, urethra, bladder, and each UVJ as previously
described.32 Male dogs had retrograde cystoscopy performed with a
flexible cystoscope (flexible endoscope, Flex X2, 2.7 mm, Karl Storz
Endoscopy-America; flexible endoscope, Flex XC, 2.7 mm, Karl Storz
Endoscopy-America) to evaluate the urethra, bladder, and UVJs fol-
lowed by either retrograde percutaneous perineal access cystoure-
throscopy (PPAC) or antegrade percutaneous cystourethroscopy (APC)
with a rigid cystoscope (2.7 mm; rigid endoscope, 2.7 mm 30 lens with
14 fr integrated sheath, Richard Wolf, Vernon Hills, Illinois; rigid endo-
scope, 2.7 mm 30 lens, Karl Storz Endoscopy-America; Cystoscope-
urethroscope sheath, 14.5 fr, Karl Storz Endoscopy-America).33–35 The
decision to perform PPAC or APC for male dogs was based on size with
an approximately 10 kg cutoff to accommodate a 14 or 16 fr peel-away
introducer sheath (14 or 16 fr peel-away introducer sheath, Cook Medi-
cal, Bloomington, Indiana) in the pelvic urethra.33,35 Retrograde uretero-
pyelography with concurrent cystourethrography was performed to
determine if ectopic ureters were intramural or extramural.32 Intramural
ectopic tracts were corrected with the laser.32
A UO with an associated ureterocele was identified (Figure 1). If
the UO was stenotic but able to be catheterized with an angle-tipped
hydrophilic guide wire (0.02500 or 0.03500) (Weasel Wire 0.025- or
0.035-in. hydrophilic angle-tipped guidewire; Infiniti Medical LLC,
Menlo Park, California) and an open-ended ureteral catheter (4 or 5 f.
open-ended ureteral catheter; Cook Medical Inc), the ureterocele was
lasered via a central linear incision with an end-fire laser fiber (diode
[600-μm diode laser fiber and 25-W diode laser; Lumenis Inc, Santa
Clara, California] or holmium, yttrium, aluminum, and garnet laser
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[Hol:YAG; 550-μm Hol:YAG SlimLine laser fiber, Boston Scientific
Corp, Natick, Massachusetts; VersaPulse Power Suite Holmium 20 W,
Lumenis]) over the catheter/wire combination32 (Figure 1). If the ure-
terocele was unable to be catheterized (imperforate) (Figure 2), laser
puncture was performed before catheterization. The cystoscope was
deflected toward the urethral lumen to angle the laser fiber tip toward
the medial aspect of the ureterocele, avoiding the lateral aspect of the
bladder or urethral wall. The medial aspect of the ureterocele was cut
in a linear continuous manner by use of the diode laser at 5-25 W
(600-μm diode laser fiber and 25-W diode laser; Lumenis Inc) or a
pulsed manner by the use of the Hol:YAG laser (20 Hz and 0.5 J at a
pulse width of 350 milliseconds; 550-μm Hol:YAG SlimLine laser
fiber, Boston Scientific Corp; VersaPulse Power Suite Holmium 20 W,
Lumenis). When the neo-UO was within the urinary bladder lumen (for
ectopic ureteroceles) or subjectively open enough to allow a ureteral
lumen to be visualized accepting the guide wire and catheter, laser abla-
tion was terminated. Retrograde contrast urethrocystography and ure-
teropyelography were performed to ensure that there was no contrast
extravasation, no ureteral obstruction, and that the flow of contrast to
the urinary bladder was appropriate. This also documented the new loca-
tion of the UO relative to the urethrovesicular junction.32,34 (Figure 2).
After completion of ureterocele CLA in females, the parameso-
nephric remnant, if present, was laser ablated.32,36 Contralateral ectopic
ureter CLA was performed if necessary.32
3 | RESULTS
3.1 | Population
Review of medical records revealed 13 dogs that had CLA attempted.
Eight dogs were seen at the Animal Medical Center (2009-2017) and
5 dogs at the Small Animal Hospital of Purdue University (2008-2017).
None of these dogs were excluded from the study. Three dogs from
the Animal Medical Center had been previously included in a prior pub-
lication describing treatment of a series of dogs with UO obstruction.30
The focus of that paper was not on ureteroceles, so these individual
dogs were not thoroughly described and were therefore included in this
study.30
3.2 | Preoperative findings
3.2.1 | Signalment
Six male dogs (4 neutered and 2 sexually intact) and 7 female dogs
(4 neutered and 3 sexually intact) were included, with a median age of
1 year (range, 2 months to 9 years) and weight of 23 kg (range,
7.88-45.2 kg). Dogs included 7 Labrador Retrievers, 2 Golden Retrievers,
FIGURE 1 Endoscopic and fluoroscopic images of a left ectopic
ureterocele in a 6-month-old female intact Labrador Retriever with
bilateral ureteral ectopia. The dog is positioned in dorsal
recumbency. A, Endoscopic image of the fluid filled intramural ectopic
ureteral tunnel causing the ureterocele within the urethral lumen.
B, A catheter visualized inside the stenotic orifice of the ectopic
ureteral opening within the urethra. C, Fluoroscopic imaging of the dog
with a guide wire and catheter advanced up the left ureter with a
cystoscope at the trigone of the urinary bladder. There is contract
material in the urinary bladder. D, A retrograde ureteropyelogram of
this dog through the ureteral catheter. Notice the ureteral tunnel
entering the bladder appropriately but traveling distally down the
urethra. This is an intramural ectopic ureter with severe hydroureter.
E, Endoscopic image of a diode laser fiber ablating the stenosis to open
the ureteral orifice. F, The laser fiber (green) is cutting the intramural
medial wall of the ectopic ureter with a ureteral catheter (orange)
placed inside the ureteral lumen. Notice the orifice is now open and the
fluid filled structure is gone. G, After completion of laser ablation, the
ureteral catheter (orange) is seen exiting the neoureteral orifice within
the urinary bladder. H, A fluoroscopic image of the neoureteral orifice,
marked by the tip of the cystoscope showing it is now in front of the
urethrovesicular junction. I, An endoscopic image of the urethra after
complete laser ablation of the ureteral tunnel. J. Final image of the
neoureteral orifice after ablation is complete in the urinary bladder
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FIGURE 2 Endoscopic and fluoroscopic images of a 2-month-old male intact Labrador Retriever with severe left hydroureter and hydronephrosis
and an imperforate orthotopic ureterocele on the left and an ectopic ureter on the right. This procedure was performed from an antegrade
cystoscopy approach owing to the small size of the canine pelvic urethra limiting the ability to perform percutaneous perineal access
cystourethroscopy. The dog is in dorsal recumbency. A, A large fluid-filled structure covering the left ureteral orifice. There is no orifice seen.
B, A diode laser is used to puncture the fluid-filled structure. C, The orifice in the structure is expanded with the laser and then the scope is used
to explore the structure (D). D, The ureteral opening is seen inside this fluid-filled structure and is largely dilated. E, A digital subtraction contrast
study is done using as a retrograde ureterogram up the ureteral orifice showing the severe hydroureter and hydronephrosis. F, Contrast is
injected into the cyst after it is opened using a ureteral catheter, and the cyst and wall can be seen inside the urinary bladder as contrast refluxes
retrograde up the ureteral orifice. G, Laser ablation of the contralateral ectopic ureter from an antegrade approach as the ureteral orifice could
not be cannulated retrograde owing to the small size of the canine penis at this young age. H, Endoscopic image after both orifices are open and
the filled cystic structure was ablated
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and 1 of each of the following Basset Hound, Chow Chow, Cocker
Spaniel, and mixed breed.
3.2.2 | Clinical signs
Data regarding clinical signs was available for all dogs. Nine of 13 dogs
were incontinent and 3 of 13 dogs were pollakiuric. One dog had
vomiting and difficulty rising. No dogs were both incontinent and pol-
lakiuric. Duration of presenting clinical signs was available for 12 dogs.
Median duration of clinical signs was 6 months (range, 2 weeks-
3 years). One dog had a history of struvite cystolithiasis. One dog had
previously undergone episioplasty surgery. Nine of 13 dogs presented
for incontinence, and 3 of 13 dogs presented for pollakiuria. One dog
presented for vomiting and difficulty rising.
3.3 | Physical examination
Vital signs were within normal limits for all animals. One dog was pain-
ful on abdominal palpation. One dog had referred upper airway
sounds on thoracic auscultation and was diagnosed with an elongated
soft palate and hiatal hernia. One dog had perivulvar urine scald. None
of the dogs had an abnormal rectal examination. None of the females
had digital vaginal palpation performed.
3.4 | Continence scoring
Data regarding continence was available for all dogs (Appendix 1). The
median preprocedure continence score was 5 (range, 1-10). Nine of
13 were noted to be incontinent and 4 continent, preoperatively. The
4 dogs noted to be continent were pollakiuric (n = 3) and had vomiting/
difficulty standing (n = 1). Two of the incontinent dogs were being trea-
ted with continence medications preoperatively but remained inconti-
nent. One dog was receiving phenylpropanolamine (0.63 mg/kg PO
q12h; Proin, PRN Pharmacal, Pensacola, Florida), another was receiving
phenylpropanolamine (1.4 mg/kg PO q12h; Proin, PRN Pharmacal),
diethylstilbestrol (0.03 mg/kg PO once weekly; diethylstilbestrol, com-
pounding pharmacy), and imipramine (0.28 mg/kg PO q12h; Tofranil;
Mallinckrodt Inc, St. Louis, Missouri).
3.5 | Clinicopathologic data
CBC and serum biochemical profiles within 14 days before CLA were
available for all the dogs. Preoperative azotemia was present in 2 dogs.
One dog had values of creatinine 1.3 mg/dL (reference: 0.3-1.2 mg/dL)
and BUN 29 mg/dL(reference range, 7–29 mg/dL) with a USG of
1.015. The other had values of creatinine 2.2 mg/dL and BUN 30 mg/dL
with a USG of 1.019. One dog had hypoalbuminemia 2.1 g/dL (reference
range, 2.5-4.0 g/dL) preoperatively. No additional CBC or serum bio-
chemical abnormalities were noted preoperatively.
Preoperative urine bacteriologic culture and sensitivity was per-
formed in 9 of 13 dogs (69%) within 60 days before the procedure
(median, 15.5 days; range, 5-57 days). Urine was obtained via cysto-
centesis. Six cultures were negative for bacterial growth. However, 3 of
6 dogs with cultures negative for growth were on antibiotics for previ-
ously diagnosed bacterial cystitis at the time of the culture. Three cul-
tures were positive for growth including Alpha-hemolytic streptococcus
(1), Escherichia coli (1), and a combination of E. coli and Proteus mir-
abilis (1).
3.6 | Diagnostic imaging
Pretreatment abdominal ultrasound was performed in 12 of 13 (92%) dogs.
Ureteroceles were identified ultrasonographically in 8 of 12 (67%) dogs.
Ten of 12 (83%) ultrasound reports described a hydroureter (ipsi-
lateral [5 dogs] or bilateral [5 dogs]). Hydroureter measurements were
provided for 4 dogs (median 10 mm; range, 5-40 mm). One ultrasound
report described unilateral ureterocele associated with ureters lacking
dilatation. Eleven of 12 (92%) ultrasound reports described the architec-
ture of 12 renal units associated with ureteroceles. Ten of 12 (83%)
renal units were noted to have preoperative renal pelvic dilatation, most
of which was characterized as severe. Only 2 renal pelvis sizes were
quantified at 4 and 2 mm in the transverse plane, respectively.
Multiple ultrasound reports were available for review in the dog with
previous ectopic ureter reimplantation. Two weeks post-neoureterocys-
tostomy, cystitis with a solitary urinary bladder polyp and granulation tis-
sue at the level of both neoureterostomy sites were described. Nine
months later, a report described a prostatic cyst with severe cystitis.
Drainage of the cyst and aerobic culture and sensitivity showed no
growth with resolution of the pollakiuria. The lesion recurred 3 months
later; it was thought to be a ureterocele from the prior ureteral remnant
of the previously repaired ectopic ureter.
Only one dog had excretory urography performed with fluoros-
copy revealing dilatation of the distal ureteral extremity consistent
with a ureterocele. Three dogs had preoperative CT scans performed.
One CT report was not available other than a conclusion of diagnosis
of a ureterocele. One CT involved an intravenous pyeloureterogram and
urethrogram in the dog with previous ectopic ureter reimplantation. This
revealed a fluid-filled cystic structure communicating with the urethra,
suspect right ureterocele. All 3 CT scans positively identified the ureter-
oceles, which were confirmed cystoscopically or surgically.
3.7 | Intraoperative findings
3.7.1 | Diagnostic cystourethroscopy
All ureteroceles were confirmed using cystourethroscopy. Eight of
13 ureteroceles were confirmed cystoscopically to be right sided, 4 were
left sided, and 1 ureterocele extended bilaterally, with an orthotopic cen-
trally located cyst-like structure encompassing both of the canine UOs.
Ten of 14 (71%) UOs associated with the ureteroceles were ectopic.
One additional dog with an orthotopic ureteroceles had a contralateral
ectopic UO. This resulted in 11 of 13 (85%) dogs with ectopia. Ectopic
ureteroceles were present in 10 of 13 (77%) dogs. Bilateral ectopia was
present in 8 of 11 (73%) dogs. Two of 13 dogs lacked ectopia.
Of the 11 dogs with an ectopic ureterocele or an ectopic contralat-
eral ureter, 8 were incontinence, 2 were pollakiuric, and 1 had vomiting
and difficulty rising. Of the 2 dogs lacking ectopia, 1 was pollakiuric and
the other was incontinent (the dog with a bilateral ureterocele).
Each ureterocele was associated with either a stenotic but patent
UO or a completely imperforate UO cystoscopically. Six of 12 (50%) uni-
lateral ureteroceles were noted to end in blind sacs with completely
imperforate or unidentifiable UO. Six of 12 (50%) unilateral ureteroceles
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had stenotic but patent UOs. Two unilateral ureteroceles noted to have
stenotic UOs also had contralateral UO stenosis. Both these dogs only
had unilateral hydronephrosis on the side of the ureterocele. Uretero-
pyelogram revealed hydronephrosis and hydroureter ipsilateral to the
ureterocele in all cases other than the dog with a prior ureteral reimplan-
tation. Ureteropyelography was not performed on the contralateral kid-
ney/ureter in all cases, unless there was an associated hydroureter,
hydronephrosis, or both conditions present. Ureteropyelogram results
were not at all consistent with ultrasound findings.
Of the 7 Labrador Retrievers, 2 (29%) had completely imperforate
or unidentifiable UOs, 3 (43%) had patent but stenotic UOs, and 2 did
not have data regarding patency of the UOs. One Labrador Retriever
and 1 mixed breed dog had bilateral UO stenosis. All ectopic ureters
and ectopic ureteroceles were intramural.
3.8 | Procedures
Treatment was accomplished via retrograde cystoscopy (7 females),
APC (2 males), or PPAC (4 males).
All 7 females successfully underwent standard retrograde cystoure-
throscopy and no surgical conversion was necessary. Surgical duration
was available for 4 female dogs with a median of 58 minutes (range,
35-150 minutes). For the 6 male dogs, 2 underwent an APC approach
and 4 underwent a PPAC approach. APC was performed in male dogs
weighing 10.8 and 7.8 kg. Percutaneous perineal access cystourethro-
scopy dogs weighed a median of 27.2 kg (range, 19-45 kg). Two male
dogs required surgical conversion. One dog undergoing APC approach
required surgical conversion because of failure to endoscopically iden-
tify the orifice to the ureterocele. The dog had bilateral intramural
ectopic ureters surgically reimplanted with distal tract ligation 2 years
prior. A ureterocele of the distal ligated intramural ectopic ureteral tract
developed as the tunnel resulted in an infected, inspissated intramural
ureterocele causing a urethral obstruction. A ureteroceleostomy and
ureterocele omentalization was performed.23,31
In another dog, a PPAC approach was performed and a ureterocele
was noted in the central trigone with unidentifiable orifices. A blind
incision was made into the ureterocele with a 600-μm diode laser
(Lumenis Inc). No urine was noted coming from incision; there was con-
cern for contrast extravasation from this incision, so the procedure was
converted to a laparotomy. No leakage was confirmed upon opening.
The ureterocele was resected with a 600-μm diode laser (Lumenis Inc)
during antegrade transurethral cystoscopy that was performed concur-
rently during a laparotomy to assist in gaining access to the remnant
ureteral lumen. Because the orifice within the urethra was imperforate,
access was unable to be obtained with cystourethroscopy alone. This
approach also allowed external ureteral resection surgically and intra-
luminal orifice extension endoscopically, without the need for a ure-
throtomy. Closure of the urinary bladder and resection of the distal
ureter was routine. Contrast cystography showed no leakage from the
bladder after closure.
Duration of the procedure was available for 5 of 6 male dogs and
was a median of 88 minutes (range, 79-95 minutes) when CLA of ure-
teroceles was performed. In the 2 cases that required surgical conver-
sion, duration of procedure was 210 and 110 minutes, respectively.
Seven of 13 dogs had additional surgical procedures performed, which
were not distinguished in surgical times from ureterocele ablation.
Procedures included staphylectomy (n = 1), CLA of persistent parame-
sonephric septal remnants (n = 2), CLA of contralateral ectopic ureters
(n = 7), and a bilateral closed neuter (n = 1).31,32,35,36
Five cases used a 400-μmHol:YAG (550-μmHol:YAG SlimLine laser
fiber, Boston Scientific Corp) laser fiber, 6 cases used a 600-μm diode
laser fiber (Lumenis Inc), 1 case that was converted to a laparotomy used
a combination of 600-μm diode laser fiber (Lumenis Inc) and a scalpel
blade to puncture the ureterocele, and 1 case that was converted to a
laparotomy used monopolar cautery for ureterocele puncture.
3.9 | Microbiologic Testing
Urine bacteriologic culture and sensitivity at the time of the procedure
was performed in 10 of 13 (77%) dogs; urine was obtained via the cys-
toscope. Three dogs had urine cultures positive for the growth of
Enterococcus (1), Staphylococcus pseudointermedius (1), and Pseudomo-
nas (1). The 3 dogs that did not have urine cultures submitted at the
time of the procedure had urine cultures negative for bacterial growth
2-4 weeks preoperatively.
3.10 | Postoperative findings
3.10.1 | Short-term outcomes
All dogs survived to discharge. No complications were noted in the
short-term postoperatively from the CLA procedure.
3.11 | Clinical signs
Short-term follow-up data was available for 12 of 13 dogs. Eleven of
12 (92%) dogs had continence scores of 10/10; these dogs had a median
continence score of 5 (range, 1-10) preoperatively. One dog scored
7.5/10, increased from 5/10 preoperatively. Two of the 11 fully conti-
nent dogs remained on continence medications indefinitely (1 dog was
receiving phenylpropanolamine and estriol and 1 was receiving phenyl-
propanolamine and diethylstilbestrol, doses unknown), and it was unclear
whether they had been attempted to be weaned off from the history,
records, or client interview. These 2 dogs had scores of 5 and 1 preopera-
tively. The 2 of 3 dogs with pollakiuria before CLA had resolution of the
pollakiuria; the final dog had resolution with initiation of doxycycline
11.6 mg/kg PO q24h (Merrem, Pfizer, New York City, New York).
3.12 | Clinicopathologic data
Short-term aerobic urine cultures were performed via cystocentesis on
4 dogs (median, 14 days; range, 14-22 days postoperatively). All were
negative for bacterial growth. Three dogs were not on antibiotics and
1 dog was on enrofloxacin (Baytril; Bayer, Shawness Mission, Kansas)
12.4 mg/kg PO q24h targeting the sensitivity for a previously cultured
Staphylococcus pseudointermedius.
3.13 | Long-term outcomes
The median long-term follow-up for all dogs was 27 months (range,
3-96 months). No long-term complications were noted from the CLA
procedure.
6 ROGATKO ET AL.
3.14 | Clinical signs
The median postoperative continence score at the time of last follow-
up was 10 (range, 3-10). Twelve of 13 dogs were fully continent at
last follow-up. The dog with a continence score of 7.5 two weeks
postoperatively became fully continent within weeks of discharge.
One dog with a continence score of 1 preoperatively and no 2-week
follow-up score available remained incontinent. This dog was esti-
mated to have a continence score of 2-4 long term despite continence
medications (medications and dose unknown) 2 years postoperatively.
This was based on referring veterinarian communications, because the
owner was deceased. After treatment, incontinence resolved in 8 of
9 (89%) dogs.
For the 3 dogs who presented with pollakiuria, all had long-term
resolution.
3.15 | Clinicopathologic data
Long-term aerobic urine cultures were performed on 8 of 13 dogs at a
median of 3 months (range, 45 days to 24 months) postoperatively.
Only 2 female dogs had urine cultures positive for bacterial growth,
both with growth of E. coli. Both these dogs had positive growth of
this organism preoperatively. After a 6-week course of meropenem
(12 mg/kg SC q12h; Baytril, Bayer) one of these dogs had urine cul-
tures negative for growth at 3, 4, and 10 months postoperatively. The
second dog with E. coli growth did not have additional urine culture
data available.
Serum biochemistry results were available for 7 dogs at a median
of 2 months (range, 2-24 months) postoperatively. Only 1 dog was azo-
temic postoperatively. This was a dog with preoperative creatinine and
BUN of 2.2 and 30 mg/dL, respectively. The azotemia had progressed
to values of creatinine 2.4 mg/dL and BUN 28 mg/dL, 2 months post-
operatively and then to creatinine 5.4 mg/dL and BUN 64 mg/dL
18 months postoperatively. This dog was suspected to have renal dys-
plasia based on the bilaterally dysplasic renal architecture noted on pre-
operative and postoperative ultrasonography.
3.16 | Diagnostic imaging
Postoperative ultrasound reports were available at a median of 4 months
(range, 36 days −18 months) postoperatively in 6 dogs. Postoperative
ultrasound reports described the ureteral diameters of 5 dogs. Only 1 of
5 dogs described a persistent, but improved, hydroureter. The diameter
decreased from 40 mm preoperatively to 4 mm postoperatively. Three
postoperative ultrasound reports described static hydroureter measure-
ments over a 2.5-year period. The remaining 4 ureters were noted to be
of normal diameter and thickness, indicating resolution of hydroureter in
4 of 5 dogs.
Six postoperative ultrasound reports commented on renal pelvic
diameter. All 6 reports had described preoperative pyelectasia. Three
of 6 postoperative reports described ultrasonographic resolution of
pyelectasia on the side of the ureterocele, whereas pyelectasia per-
sisted in 3 of 6 dogs. One dog with persistent pyelectasia had ultraso-
nographic changes consistent with renal dysplasia, which were noted
both preoperatively and 6 months postoperatively. Hydroureter or
pyelectasia was not noted to worsen postoperatively in any of these
reports.
3.17 | Long-term Outcomes
One dog was euthanized due to diffuse hepatic and splenic neoplasia
2 years post-CLA. One dog had a 1.5 cm apical bladder mass diagnosed
2 years post-CLA. A urothelial carcinoma, grade 2, was completely sur-
gically excised. Postoperative chemotherapy was pursued, and the dog
was followed up for 538 days until death from cause unknown.
4 | DISCUSSION
Results of the present study suggest that the use of a minimally inva-
sive CLA procedure is a safe and effective treatment for ureteroceles
in most dogs. This technique can avoid the need for more invasive
surgery in most cases, especially in female dogs. It also suggests that
ureteroceles in dogs are most commonly associated with a stenotic
UO which can be associated with an ectopic ureter. They typically
cause at least partial ureteral obstruction and should be treated to
prevent renal injury. When successful, this procedure enabled a rapid
and effective decompression of the ureterocele with low morbidity. In
this population, 12 of 13 dogs (5/6 males, 7 females) had cystoure-
throscopy to diagnose a ureterocele. Eleven of 13 were able to be
successfully approached using endoscopy alone, with the other 2 dogs
being diagnosed with a UO stenosis using endoscopy, which then sub-
sequently required surgical assistance for fixation. In all dogs, clinical
assessments after fixation of the ureterocele were consistent with
resolution of ureterocele. Surgical conversion was needed in 2 males.
No postoperative complications were noted. Resolution of pollakiuria
was noted in all cases and resolution of urinary incontinence was
noted in most cases.
Of the 11 dogs with ectopia, 8 were incontinent (73%), 2 were polla-
kiuric, and 1 had vomiting/difficulty rising. Of the 2 dogs lacking ectopia,
1 had pollakiuria and 1 was incontinent. This is comparable to previous
reports where 9 of 10 (90%) dogs with ectopic ureteroceles were incon-
tinent and only 2 of 7 (29%) dogs with orthotopic ureteroceles were
incontinent.14–29 This suggests that not all ectopic dogs are incontinent
and not all orthotopic dogs are continent, but if incontinence is present it
can be more likely that the dog is concurrently ectopic.
The UO pathology associated with the ureteroceles is suggestive of
a congenital etiology and is supported by the early age (median age
1 year) of diagnosis in this population. In previously described uretero-
cele cases, only 4 of 20 dogs were Labrador Retrievers. 14–30 In this
series, Labrador Retrievers seemed subjectively overrepresented (7/13;
54%). Labrador Retrievers have been previously described as a breed
documented to have congenital UVJ stenosis30 but most commonly
without a ureterocele. Ten of 14 (71%) UOs associated with the ureter-
oceles were ectopic in this study. This is similar to historic rates of
ectopic ureteroceles (59%).14–29 Ectopia is thought to be of a congenital
etiology,32 further supporting a congenital basis for ureterocele forma-
tion in dogs.
In the human literature, there is controversy regarding etiology of
ureteroceles identified in adulthood; it is thought that trauma or
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inflammation to the UO can result in stenosis and subsequent dilatation
of the intramural distal ureter, appearing as an intravesicular cystic
structure.37–39 Based on the history of this dog, this was considered a
remnant ureterocele that was intermittently infected owing to stagnant
urine accumulation. This study included 4 dogs older than 2 years, sug-
gesting that an acquired pathogenesis cannot be excluded. One of the
ureteroceles was suspected to be acquired secondary to surgical liga-
tion of intramural ectopic ureters. Formation of a ureterocele after
intramural ectopic ureter anastomosis and continued reflux of urine
into the intramural ureter has been reported.25 Additional research is
needed to understand etiology of ureteroceles in dogs.
In this case series, incontinence and pollakiuria resolved in 8 of
9 and 3 of 3 dogs after treatment long-term. Because of the small
number of cases reported with ureteroceles in both the surgical and
interventional literature, it is difficult to say whether CLA provides an
advantage in postoperative continence rates, compared with that of
traditional surgery. The median surgical time of 58 minutes in female
dogs coupled with the 0% surgical conversion rate and 89% conti-
nence rate would support that this is a highly successful modality to
consider for the treatment of this condition.
The main complications that could occur with CLA are iatrogenic
ureteral, bladder, or urethral wall perforation with the laser, leading to
urinary leakage. Urine extravasation was suspected in 1 male dog that
was treated using PPAC. Due to the thickness of the wall of the ure-
terocele and failure to cannulate from complete stenosis of the orifice,
blind ablation was attempted. Surgical conversion was then pursued.
No postoperative complications were noted as a result of conversion
or from urine extravasation. Difficulty visualizing extraluminal struc-
tures is also a potential complication. In 1 dog who had previous reim-
plantation surgery, an open approach was elected for visualization
and to remove a permanent suture that had been previously placed
around an intramural ectopic ureter extraluminally, as this could be a
source of the abscessed intramural ureteral lumen. Omentalization
was also performed. None of the dogs required a second procedure to
address persistent clinical signs postoperatively, in contrast to previ-
ous surgical reports.21,23 Bleeding, stricture, vaginal tears, and uretero-
cele recanalization are other theoretical risks36,40 which were not
documented in any of these dogs.
Abdominal ultrasound examinations were performed preopera-
tively in 12 of 13 dogs. Only 8 of 12 (67%) dogs had ureteroceles pos-
itively identified on ultrasound. Preoperative ultrasound described
10 of 12 (83%) hydroureters, yet intraoperative ureteropyelography
revealed hydroureter ipsilateral to the ureterocele in all cases other
than the dog with a prior ureteral reimplantation. In a human study of
the sensitivity of ultrasound for hydroureter resulting from nephro-
lithiasis and ureterolithiasis, the sensitivity for detection of hydrour-
eter was only 50%.41 In this study, these differences could have been
due to differences in operator skill and variation in dog conformation.
Human studies similarly cite the sensitivity and specificity of ultra-
sound for the detection of hydronephrosis as being highly dependent
on hydration status with values of 100% and 84%, respectively, for
hydrated patients and 35%-73% and 74%, respectively, for nonhy-
drated patients.42,43 Hydration status of the dogs could have affected
ultrasonographic identification of hydroureter and hydronephrosis in
this study. The lack of bladder or urethral distention might have made
the imaging difficult. Computed tomographic scan positively identified
all ureteroceles; however, only 3 dogs underwent this modality. All
but 1 ureterocele were cystoscopically confirmed, the orifice location
identified and treatment attempted at the same time. Because of this,
cystourethroscopy is the authors' diagnostic test of choice for the
diagnosis and simultaneous treatment of both ectopic ureters and ure-
teroceles, avoiding the need for more expensive imaging modalities. In
1 case, the ureterocele's communication with the bladder was unable
to be identified cystoscopically. Ultrasound-guided percutaneous injec-
tion of a radiopaque or colored contrast agent could have facilitated
fluoroscopic and endoscopic identification.
On preoperative ultrasound reports, 10 of 12 dogs had hydrour-
eter and a dilated renal pelvis. When reevaluated postoperatively, 1 of
5 had some hydroureter, but it was improved, and 3 of 6 had some
evidence of persistent renal pelvic dilatation. Persistence of the hydro-
ureter or hydronephrosis could have been due to the chronic nature of
the obstructive lesion leading to stretch, the presence of additional con-
genital abnormalities in the ureters (megaureter), stricture formation at
the CLA site, or fibrosis from chronic obstruction.
The previously reported clinical findings of pollakiuria, bacterial
cystitis, and urinary incontinence in dogs with ureteroceles,42 were
consistent with findings in the 12 of 13 dogs in this study, with 1 dog
presenting for vomiting/difficulty standing. In the latter dog, the ure-
teroceles was likely an incidental finding to gastroenteritis that resolved
with supportive care. In the human literature, the treatment of clinically
silent ureteroceles is recommended due to the potential risk of UTI,
persistent ureteral outflow tract obstruction, and the loss of renal func-
tion.12 The treatment of asymptomatic ureteroceles in veterinary medi-
cine should also be considered.
Azotemia was present in only 2 of 13 dogs preoperatively and
1 of 7 dogs postoperatively. The dog with progressive persistent azo-
temia was noted to have dysplastic architecture of the kidneys on pre-
operative and postoperative ultrasound imaging. However, without
obtaining renal biopsies, the exact etiology is unknown. Hydroureter
has been reported to predispose to increased hydrostatic pressure
and permanent renal damage.15 Additional research would be required
to understand if the progressive disease was primary renal dysplasia,
progressive renal damage from chronic ureteral obstruction, or vesicu-
loureteral reflux from a large UO after fixation.
In this study, a single laser incision was utilized. No evidence of
vesicoureteral reflux was appreciated on postoperative imaging, but
follow-up contrast retrograde cystourethrography to test for uretero-
vesicular reflux was not performed. Assessing outcomes of multiple,
solitary punctures creating a “watering-can” appearance44 versus a
single laser incision in the cystoscopic treatment of ureteroceles in
dogs is another potential area of research, but with the positive out-
comes shown here, this might be unnecessary.
Evaluation for long-term ureterovesicular reflux using voiding
cystourethrograms would be helpful to determine if there is concern.
Because of the excessively long ureter seen in dogs, compared to peo-
ple, the development of clinically relevant UVJ reflux is highly unlikely.
Clinically, with the resolution of ureteral dilatation, improvement of
renal pelvic dilatation, improvement in urinary incontinence, and polla-
kiuria, along with the improved rate of UTIs, and failure of progressive
azotemia, the likelihood of reflux creating a clinical problem is low.
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The limitations of this study include its retrospective nature and
lack of standardized follow-up. However, these results represent a
standardized cystoscopic approach performed by 2 institutions with
specialists trained in endourology. Both institutions had comparable
outcomes. Differential glomerular filtration rate (GFR) studies were
not performed to evaluate renal function before and after CLA. Ure-
thral pressure profilometry was not performed to assess concurrent
urethral sphincter mechanism incompetence; it is possible that ure-
thral sphincter mechanism incompetence contributed to clinical signs.
However, given the high resolution of incontinence with CLA, this
was not clinically impactful. Given the rare incidence of ureteroceles
in dogs, this case series possesses the largest number of cases when
compared to the current literature and can help form the basis for fur-
ther comparison studies.
In conclusion, ureteroceles are a rare condition in dogs but should
be considered as a differential for dysuria or incontinence, with con-
current hydroureter. Cystoscopic-guided ureteral ablation was a safe,
effective, and minimally invasive technique for treating UO stenosis
associated ureteroceles in most dogs. Ureteroceles are commonly
associated with ureteral ectopia but can be orthotopic as well. They
are uncommonly associated with azotemia. Dogs with ureteroceles
should be considered to have a good to excellent prognosis and renal
sparing treatments should be encouraged. Prospective studies are
warranted to assess short- and long-term outcomes, the presence of
ureterovesicular reflux, and to compare laser ablation to other surgical
techniques.
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APPENDIX
Urinary continence score (1-10).
1 = Leaking when walking, running, playing, and sleeping, never
urinates a full bladder.
5 = Leaking mainly when laying down; minimally when walking or
playing; leak immediately before or after urination.
7.5 = Only leaking when sleeping
9 = Notice urine on fur a few times per week.
10 = No leaking known at all.
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